Manages manifestations of psychotic disorders. ANDA 84115, held by Upsher Smith Labs. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 84115 (Chlorpromazine Hydrochloride), held by Upsher Smith Labs, was first approved by FDA on Jul 9, 1974, with 30 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the treatment of tetanus. To control the manifestations of the manic type of manic-depressive illness. For relief of intractable hiccups.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 9, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride200MG · tablet;oral | Chlorpromazine Hydrochloride | RxReference drug |
| Feb 5, 2020 | Supplement 112Labeling · Standard review | Approved | None posted |
| Feb 23, 2017 | Supplement 108Labeling · Standard review | Approved | None posted |
| Aug 29, 2016 | Supplement 107Manufacturing | Approved | None posted |
| Sep 13, 2011 | Supplement 103Labeling | Approved | None posted |
| Dec 3, 2010 | Supplement 100Labeling | Approved | None posted |
| Aug 24, 2009 | Supplement 97Labeling | Approved | None posted |
| Nov 19, 2008 | Supplement 94Labeling | Approved | None posted |
| Nov 25, 2002 | Supplement 79Labeling | Approved | None posted |
| Mar 22, 1999 | Supplement 78Labeling | Approved | None posted |
| Mar 22, 1999 | Supplement 77Manufacturing | Approved | None posted |
| Feb 5, 1996 | Supplement 76Manufacturing | Approved | None posted |
| Sep 16, 1992 | Supplement 75Labeling | Approved | None posted |
| Dec 31, 1991 | Supplement 74Labeling | Approved | None posted |
| Nov 29, 1990 | Supplement 73Labeling | Approved | None posted |
| Apr 14, 1989 | Supplement 72Manufacturing | Approved | None posted |
| Jul 5, 1988 | Supplement 70Manufacturing | Approved | None posted |
| Apr 26, 1988 | Supplement 71Labeling | Approved | None posted |
| Apr 14, 1988 | Supplement 68Manufacturing | Approved | None posted |
| Mar 8, 1988 | Supplement 69Labeling | Approved | None posted |
| Dec 8, 1987 | Supplement 67Manufacturing | Approved | None posted |
| Dec 8, 1987 | Supplement 65Manufacturing | Approved | None posted |
| Dec 8, 1987 | Supplement 64Manufacturing | Approved | None posted |
| Sep 5, 1986 | Supplement 62Manufacturing | Approved | None posted |
| Jul 10, 1986 | Supplement 61Manufacturing | Approved | None posted |
| Jul 10, 1986 | Supplement 60Manufacturing | Approved | None posted |
| Jun 26, 1985 | Supplement 55Manufacturing | Approved | None posted |
| Jun 26, 1985 | Supplement 54Manufacturing | Approved | None posted |
| Jun 14, 1984 | Supplement 49Manufacturing | Approved | None posted |
| Jun 11, 1982 | Supplement 46Manufacturing | Approved | None posted |
| Apr 26, 1982 | Supplement 47Manufacturing | Approved | None posted |
| Jul 9, 1974 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters